Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group.

Abstract	The clinical efficacy and safety of 3.75 or 7.5 mg leuprorelin acetate depot given subcutaneously once every 4 weeks was evaluated in a collaborative study of 81 patients with untreated prostatic cancer. Efficacy of treatment was assessed using criteria based on a meeting of the Prostatic Cancer Study Group funded by the Japanese Ministry of Health and Welfare and using National Prostatic Cancer Project criteria. Japanese criteria enabled evaluation of individual parameters, unlike the National Prostatic Cancer Project system which classified a patient as unevaluable if one evaluation parameter was unavailable. Leuprorelin acetate depot suppressed serum luteinizing hormone, follicle stimulating hormone and testosterone concentrations. Objective response rates of the prostate, bone metastases, serum prostatic acid phosphatase and soft tissue metastases, and subjective dysuria and pain responses were comparable to those found with conventional hormone therapy. Leuprorelin acetate depot was well tolerated, with no significant differences in response to the two doses.
Authors	H Akaza, Y Aso, K Koiso, H Fuse, K Isurugi, K Okada, M Usami, T Kotake, T Ohashi, T Ueda
Journal	The Journal of international medical research (J Int Med Res) Vol. 18 Suppl 1 Pg. 90-102 ( 1990) ISSN: 0300-0605 [Print] England
PMID	2108889 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References	Antineoplastic Agents Delayed-Action Preparations Gonadotropin-Releasing Hormone Testosterone Luteinizing Hormone Follicle Stimulating Hormone Leuprolide
Topics	Adult Aged Aged, 80 and over Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use) Clinical Trials as Topic Delayed-Action Preparations Follicle Stimulating Hormone (blood) Gonadotropin-Releasing Hormone (administration & dosage, adverse effects, analogs & derivatives, therapeutic use) Humans Injections, Subcutaneous Japan Leuprolide Luteinizing Hormone (blood) Male Middle Aged Multicenter Studies as Topic Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!